BioCentury
ARTICLE | Company News

sanofi-aventis licenses Kyowa mAb

May 15, 2009 1:12 AM UTC

Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) granted sanofi-aventis Group (Euronext:SAN; NYSE:SNY) exclusive, worldwide rights to develop and commercialize a human mAb against tumor necrosis factor ligand ...